Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-κB and JNK activation and suppression of COX-2 activity

Bin Xing, Mei Liu, Guoying Bing

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

Increasing evidence links neuroinflammation to Parkinson's disease. Microglia are mediators of neuroinflammation. Overactivation of microglia contributes to the release of cyclooxygenase 2 and prostaglandin E2 during neuronal insults. We have previously shown that pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, inhibits microglia activation, reduces proinflammatory factors, and protects dopaminergic neurons. Here, we demonstrated that pioglitazone protects dopaminergic neurons by inhibiting abnormal microglia activation, interfering with phosphorylation of jun N-terminal kinase and nuclear factor kappa-B, and by suppressing cyclooxygenase 2 expression and the subsequent prostaglandin E2 synthesis. Therefore, the anti-inflammatory properties of pioglitazone may be useful for ameliorating the progression of Parkinson's disease.

Original languageEnglish
Pages (from-to)89-98
Number of pages10
JournalJournal of Neuroimmunology
Volume192
Issue number1-2
DOIs
StatePublished - Dec 2007

Bibliographical note

Funding Information:
The authors wish to thank Randy Hunter for his help in writing and Mei Liu for her double-immunostaining technique. The present work was supported by NIH grant NS044157 (GB).

Keywords

  • COX-2
  • Dopaminergic neurons
  • JNK
  • Microglia
  • NF-κB
  • PGE

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-κB and JNK activation and suppression of COX-2 activity'. Together they form a unique fingerprint.

Cite this